Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920278 · ClinicalTrials.gov registry record
Accuracy of Pulse Oximeters in Profound Hypoxia
A clinical trial, sponsored by Movano Health.
- Completed
- Registry status
- 11
- Enrollment target
NCT05920278: Completed study, sponsored by Movano Health.
NCT05920278 is a clinical trial that has completed, run by Movano Health. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05920278 has completed, sponsored by Movano Health.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The goal of this study was to evaluate the accuracy of pulse oximeters over the range of 70-100%. Two devices were placed on each subject with one on the finger and the other on the fingertip. SpO2 measurements from these devices were compared to sampling of arterial blood during brief stable oxygen desaturation in healthy volunteers to evaluate the claimed range.
Primary Outcome
Root Mean Squared Error between Movano Ring SpO2 measurement and the arterial blood SaO2 calibrated using arterial blood gas.
Interventions
- DEVICE Pulse oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-10-26 |
| Est. Completion | 2022-10-27 |
What the finished NCT05920278 record still lists
NCT05920278 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse oximeter is the first listed.
NCT05920278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05920278 about?
NCT05920278 is a clinical study titled "Accuracy of Pulse Oximeters in Profound Hypoxia". The goal of this study was to evaluate the accuracy of pulse oximeters over the range of 70-100%. Two devices were placed on each subject with one on the finger and the other on the fingertip. SpO2 measurements from these devices were compared to sampling of arterial blood during brief stable oxygen...
What is the current status of trial NCT05920278?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2022-10-26. Estimated completion is 2022-10-27.
What interventions are being tested in trial NCT05920278?
The interventions under investigation include: Pulse oximeter (DEVICE).
Who is sponsoring clinical trial NCT05920278?
This trial is sponsored by Movano Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI